Citi Pharma Limited (PSX:CPHL)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
89.39
+0.82 (0.93%)
At close: Aug 29, 2025
0.93%
Market Cap20.42B
Revenue (ttm)12.97B
Net Income (ttm)830.91M
Shares Out228.46M
EPS (ttm)3.64
PE Ratio24.57
Forward PE19.02
Dividend3.25 (3.64%)
Ex-Dividend Daten/a
Volume5,313,132
Average Volume7,644,941
Open88.57
Previous Close88.57
Day's Range87.71 - 90.75
52-Week Range32.15 - 109.30
Beta0.52
RSI55.18
Earnings DateOct 7, 2025

About Citi Pharma

Citi Pharma Limited engages in the manufacture and sale of pharmaceutical, medical chemical, and botanical products in Pakistan. Citi Pharma Limited was incorporated in 2012 and is headquartered in Lahore, Pakistan. [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 2012
Employees 519
Stock Exchange Pakistan Stock Exchange
Ticker Symbol CPHL
Full Company Profile

Financial Performance

In 2024, Citi Pharma's revenue was 12.41 billion, an increase of 0.10% compared to the previous year's 12.40 billion. Earnings were 833.46 million, an increase of 26.67%.

Financial Statements

News

There is no news available yet.